The use of real-world evidence can prevent pharma companies from performing studies based on flawed data.
Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Articles by Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How New Technologies Are Impacting the Vaccine Market
2
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
3
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
4
Kardigan Planning for $350 Million IPO Raise: Report
5